Please login to the form below

Not currently logged in
Email:
Password:

clopidogrel

This page shows the latest clopidogrel news and features for those working in and with pharma, biotech and healthcare.

Novartis’ Mayzent and Roche’s Polivy lead CHMP recommendations

Novartis’ Mayzent and Roche’s Polivy lead CHMP recommendations

The CHMP also recommended marketing authorisations for two generic medicines – Mylan’s Clopidogrel/Acetylsalicylic acid Mylan (clopidogrel/acetylsalicylic acid) for the secondary prevention of atherothrombotic events and Accord’s

Latest news

More from news
Approximately 1 fully matching, plus 77 partially matching documents found.

Latest Intelligence

  • Deal Watch September 2016 Deal Watch September 2016

    Zontivity is a protease-activated receptor-1 antagonist indicated for use in combination with daily aspirin and/or clopidogrel to reduce thrombotic cardiovascular events.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics